- Home
- Industry Reports
- Biotechnology
- Healthcare
- Middle East & Africa Stemcell Therapeutics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Stem cells are unspecialized cells that can develop into different types of cells which can be of same or different at the earlier stages of life and therapies helps to prevent diseases like bone marrow transplantation is most widely used stem cell therapy.
The Middle East & Africa Stemcell Therapeutics Market Segments Size & Growth:
The Middle East & Africa, stem cell therapeutics market, is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market are increasing demand for Stemcell treatment, the rise in diseased population, and advancement in research. However, complications and cost hinder the growth of the Middle East & Africa stemcell therapeutics market.
The Middle East & Africa Stemcell Therapeutics Market Segments Share:
The Middle East & Africa Stemcell Therapeutics market is categorised into by treatment which consists of syngeneic stem cell therapy, allogeneic stem cell therapy, and autologous stem cell therapy. Allogeneic stem cell therapy has the most significant share as they repair the cells fast and heals the damaged cell at a quick pace.
By Geography, South Africa is dominating the stem cell therapeutics market, and the growth in Middle East & Africa is mainly attributed because of the increasing demand for stem cell treatment and research on human tissues. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, diseases and investment in stem cell research.
The Middle East & Africa Stemcell Therapeutics Market Segments Trends:
- Latest stem cell method sheds light on indicating the sign of heart diseases for the study of vascular diseases.
- New techniques like Cellular barcoding helps the researcher understand the behaviour of stem cells, as they were able to track and define family tree of individual blood cells in an environment.
- In January 2017, Nanoparticles development platform was acquired by Cytori Therapeutics, Inc.to enhance regenerative medicine.
- In August 2017, Gilead Sciences, Inc.has been acquiring Kite Pharma, Inc. for better innovations and developments in the stem cell market.
The Middle East & Africa Stemcell Therapeutics Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Advanced Cell Technology
- Takara Bio USA Holdings, Inc.
- NsGene
- CellGenix GmbH
- Neuralstem, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in demand for Stemcell treatment
4.1.2 Rise in diseased population
4.1.3 Advancement in research on human tissues
4.2 Restraints
4.2.1 Complications in Stemcell treatment
4.2.2 High-cost procedure
4.3 Opportunities
4.3.1. Research in pharmaceutical and biotechnology
4.4 Challenges
4.4.1. To reduce contamination and cancer risk
Chapter 5 Middle East & Africa Stemcell Therapeutics Market- By Treatment
5.1 Syngeneic Stem Cell Therapy
5.1.1 Neurology
5.1.2 Cardiology
5.1.3 Oncology
5.1.4 Diabetes
5.1.5 Hematology
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Middle East & Africa Stemcell Therapeutics Market- By Geography
6.1 Introduction
6.2 The Middle East & Africa
6.2.1. The Middle East
6.2.2. Africa
Chapter 7 Middle East & Africa Stemcell Therapeutics Market- Company Profiles
7.1 Invitrogen
7.2 Advanced Cell Technology
7.3 Takara Bio USA Holdings, Inc.
7.4 NsGene
7.5 CellGenix GmbH
7.6 Neuralstem, Inc.
7.7 Aastrom Biosciences, Inc.
7.8 Osiris Therapeutics, Inc.
7.9 Kite Pharma
7.10 Novocell
7.11 Geron Corporation
7.12 Stemcells, Inc.
7.13 Cytori Therapeutics, Inc.
7.14 Cellular Engineering Technologies Inc.
7.15 Athersys
Chapter 8 Middle East & Africa Stemcell Therapeutics Market- Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,022.66 - €6,742.20
- INR: ₹180,397.12 - ₹601,323.72
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,731.96 - £5,773.21
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Stem cells are unspecialized cells that can develop into different types of cells which can be of same or different at the earlier stages of life and therapies helps to prevent diseases like bone marrow transplantation is most widely used stem cell therapy.
The Middle East & Africa Stemcell Therapeutics Market Segments Size & Growth:
The Middle East & Africa, stem cell therapeutics market, is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market are increasing demand for Stemcell treatment, the rise in diseased population, and advancement in research. However, complications and cost hinder the growth of the Middle East & Africa stemcell therapeutics market.
The Middle East & Africa Stemcell Therapeutics Market Segments Share:
The Middle East & Africa Stemcell Therapeutics market is categorised into by treatment which consists of syngeneic stem cell therapy, allogeneic stem cell therapy, and autologous stem cell therapy. Allogeneic stem cell therapy has the most significant share as they repair the cells fast and heals the damaged cell at a quick pace.
By Geography, South Africa is dominating the stem cell therapeutics market, and the growth in Middle East & Africa is mainly attributed because of the increasing demand for stem cell treatment and research on human tissues. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, diseases and investment in stem cell research.
The Middle East & Africa Stemcell Therapeutics Market Segments Trends:
- Latest stem cell method sheds light on indicating the sign of heart diseases for the study of vascular diseases.
- New techniques like Cellular barcoding helps the researcher understand the behaviour of stem cells, as they were able to track and define family tree of individual blood cells in an environment.
- In January 2017, Nanoparticles development platform was acquired by Cytori Therapeutics, Inc.to enhance regenerative medicine.
- In August 2017, Gilead Sciences, Inc.has been acquiring Kite Pharma, Inc. for better innovations and developments in the stem cell market.
The Middle East & Africa Stemcell Therapeutics Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Advanced Cell Technology
- Takara Bio USA Holdings, Inc.
- NsGene
- CellGenix GmbH
- Neuralstem, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in demand for Stemcell treatment
4.1.2 Rise in diseased population
4.1.3 Advancement in research on human tissues
4.2 Restraints
4.2.1 Complications in Stemcell treatment
4.2.2 High-cost procedure
4.3 Opportunities
4.3.1. Research in pharmaceutical and biotechnology
4.4 Challenges
4.4.1. To reduce contamination and cancer risk
Chapter 5 Middle East & Africa Stemcell Therapeutics Market- By Treatment
5.1 Syngeneic Stem Cell Therapy
5.1.1 Neurology
5.1.2 Cardiology
5.1.3 Oncology
5.1.4 Diabetes
5.1.5 Hematology
5.2 Allogeneic Stem Cell Therapy
5.3 Autologous Stem Cell Therapy
Chapter 6 Middle East & Africa Stemcell Therapeutics Market- By Geography
6.1 Introduction
6.2 The Middle East & Africa
6.2.1. The Middle East
6.2.2. Africa
Chapter 7 Middle East & Africa Stemcell Therapeutics Market- Company Profiles
7.1 Invitrogen
7.2 Advanced Cell Technology
7.3 Takara Bio USA Holdings, Inc.
7.4 NsGene
7.5 CellGenix GmbH
7.6 Neuralstem, Inc.
7.7 Aastrom Biosciences, Inc.
7.8 Osiris Therapeutics, Inc.
7.9 Kite Pharma
7.10 Novocell
7.11 Geron Corporation
7.12 Stemcells, Inc.
7.13 Cytori Therapeutics, Inc.
7.14 Cellular Engineering Technologies Inc.
7.15 Athersys
Chapter 8 Middle East & Africa Stemcell Therapeutics Market- Competitive Landscape
8.1. Market Share Analysis
8.2. Strategies Adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.